Electrophoresis · 2015 · 17 citations · 26 references
Life SciencesMolecular BiologyMolecular VirologyVaccinologyVirologyHuman Papillomavirus InfectionOncogenic VirusesViral DiagnosticsViral InfectionsViral VaccinesVirus-like Particle VaccinesAdditivesHpv Molecular DiagnosticsProphylactic Cancer VaccinesProphylactic VaccinesProphylactic Virus-like Particle VaccinesSalt Concentration EffectsWall CoatingWestern Blot Analysis
Virus-like particles of human papillomavirus (HPV-VLP), resulting from the self-assembly of the capsid proteins (L1 or L1 and L2), have been widely used to study HPV as they are similar to the native virion. Moreover, two prophylactic vaccines, Gardasil(®) and Cervarix(®), are based on HPV-VLP L1. Analytical techniques currently used to characterize HPV-VLP, such as SDS-PAGE, Western blot, ELISA, are time-consuming and semiquantitative. In this study, CE was evaluated for the analysis of intact HPV16-VLP. The usefulness of capillary inner wall coating as well as various BGEs, pH, and detergent additives were investigated. Reproducible HPV-VLP analysis in CE was achieved using poly(ethylene oxide)-coated capillary and a BGE containing high salt concentration and low SDS concentration. The developed method enables HPV-VLP detection in less than 10 min (migration times RSD: 1.6%). The identity of HPV-VLP peak was confirmed by comparison with a sample obtained from a wild-type baculovirus and with VLP-based vaccine, Gardasil(®) , after adjuvant dissolution. Finally, we applied the developed methodology to VLP-based vaccines, demonstrating that CE could be successfully used for vaccine quality control.
26
Arrangement of L2 within the Papillomavirus Capsid
Christopher B. Buck, Naiqian Cheng, Cynthia D. Thompson et al. · Journal of Virology · 2008 · 355 citations
Michel Deschuyteneer, Abdelatif Elouahabi, Dominique Plainchamp et al. · Human Vaccines · 2010 · 133 citations · Full text